FDA Approves New Lilly-Amylin Drug for Type 2 Diabetes
FDA Approves New Lilly-Amylin Drug for Type 2 Diabetes
The U.S. Food and Drug Administration approved exenatide (brand name Byetta), as an additional therapy for patients with Type 2 diabetes whose blood glucose levels are not well controlled by two oral medications....
http://www.diabetespages.com
Originally Posted on 20/05/2005 22:23:22
Content source: http://diabetes.about.com/b/a/166690.htm
0 Comments:
Post a Comment
<< Home